open access

Vol 64, No 6 (2014)
Review articles
Published online: 2015-01-08
Get Citation

Prognostic factors of brain metastases in patients with breast cancer

Tomasz Walasek, Beata Sas-Korczyńska, Paweł Blecharz, Jerzy W. Mituś, Marian Reinfuss
DOI: 10.5603/NJO.2014.0086
·
Nowotwory. Journal of Oncology 2014;64(6):496-503.

open access

Vol 64, No 6 (2014)
Review articles
Published online: 2015-01-08

Abstract

The development of brain metastases from breast cancer (BMBC) relates to poor prognosis. The median survival rate averages from 2 to 16 months and depends on various prognostic factors and therapeutic possibilities. There are some prognostic factors which were found in trials as a results of multivariate analyses and factors from prognostic scores in patients with brain metastases. According to the literature the important prognostic factors are performance status and status of the disease outside the brain. Performance status usually is evaluated according to the Karnofsky scale. Whereas the disease status is estimated variously as: presence versus no disease, controlled or uncontrolled disease, presence or not of distant metastases outside the brain. Many authors revealed that age, molecular type of breast cancer and number of brain metastases are potential prognostic factors. Published results of analyses showed that the role of some prognostic factors is limited in patients with BMBC.

Abstract

The development of brain metastases from breast cancer (BMBC) relates to poor prognosis. The median survival rate averages from 2 to 16 months and depends on various prognostic factors and therapeutic possibilities. There are some prognostic factors which were found in trials as a results of multivariate analyses and factors from prognostic scores in patients with brain metastases. According to the literature the important prognostic factors are performance status and status of the disease outside the brain. Performance status usually is evaluated according to the Karnofsky scale. Whereas the disease status is estimated variously as: presence versus no disease, controlled or uncontrolled disease, presence or not of distant metastases outside the brain. Many authors revealed that age, molecular type of breast cancer and number of brain metastases are potential prognostic factors. Published results of analyses showed that the role of some prognostic factors is limited in patients with BMBC.

Get Citation
About this article
Title

Prognostic factors of brain metastases in patients with breast cancer

Journal

Nowotwory. Journal of Oncology

Issue

Vol 64, No 6 (2014)

Pages

496-503

Published online

2015-01-08

DOI

10.5603/NJO.2014.0086

Bibliographic record

Nowotwory. Journal of Oncology 2014;64(6):496-503.

Authors

Tomasz Walasek
Beata Sas-Korczyńska
Paweł Blecharz
Jerzy W. Mituś
Marian Reinfuss

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest VM Media sp. z o.o. VM Group sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl